Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography
NCT03173066
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
1
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Embolism
Interventions
DRUG:
Ferumoxytol
Sponsor
Brigham and Women's Hospital